Caribbout Export, Corp. – Trademark Portfolio
Entity Type: 03
Caribbout Export, Corp. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 32 (Light Beverages) — 18 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 5 trademarks are registered and 5 are pending. Notable registered marks include C, CICLON ENERGY DRINK, and CICLÓN ENERGY DRINK. The owner is based in Bayamon, PR.
c/o Coca Cola Puerto Rico Bottlers
Industrial Minillas
Bayamon, PR 009591911
Showing of trademarks Trademarks
Trademark Classifications
Caribbout Export, Corp.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Caribbout Export, Corp. have?
Caribbout Export, Corp. has 19 U.S. trademarks filed with the USPTO. Of these, 5 registered, 5 pending, 6 abandoned, 3 cancelled.
What trademark classes does Caribbout Export, Corp. file in?
Caribbout Export, Corp. files trademarks across 2 Nice Classification classes. The most active classes are Class 32 (Light Beverages), Class 5 (Pharmaceuticals). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.
What are Caribbout Export, Corp.'s most well-known trademarks?
Caribbout Export, Corp.'s registered trademark portfolio includes well-known marks such as C, CICLON ENERGY DRINK, and CICLÓN ENERGY DRINK. These are among 5 currently registered trademarks in the portfolio.
What is Caribbout Export, Corp.'s trademark registration success rate?
Caribbout Export, Corp. has a 36% trademark registration rate, with 5 out of 14 resolved applications resulting in successful registration. Currently, 5 applications are pending review.